Wedbush Downgrades NovoCure Ltd. (NVCR) to Neutral

April 14, 2021 6:54 AM EDT
Get Alerts NVCR Hot Sheet
Price: $218.04 -1.92%

Rating Summary:
    7 Buy, 5 Hold, 2 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 15 | Down: 13 | New: 24
Trade Now! 
Join SI Premium – FREE

Wedbush analyst David Nierengarten downgraded NovoCure Ltd. (NASDAQ: NVCR) from Outperform to Neutral with a price target of $154.00 (from $159.00).

For an analyst ratings summary and ratings history on NovoCure Ltd. click here. For more ratings news on NovoCure Ltd. click here.

Shares of NovoCure Ltd. closed at $197.33 yesterday.

You May Also Be Interested In

Related Categories

Analyst PT Change, Downgrades